Latest Derivatives News

Bio-Gene Technology Limited has launched a Share Purchase Plan allowing Australian shareholders to invest up to $15,000 at 2.3 cents per share, matching a recent $2.1 million placement. The offer includes free-attaching options, subject to shareholder approval, to support key product development milestones.

Victor Group Holdings has established Victor Nexus Pty Ltd to deepen its fintech footprint in Australia and forged a strategic partnership with Shebah, aiming to empower women through innovative financial solutions.

Horseshoe Metals has extended the gold surface materials processing option at Horseshoe Lights to mid-2025, while advancing copper Direct Shipping Ore activities and negotiating key offtake deals.

Star Minerals has appointed ResourcesWA to manage the mine approval process for its Tumblegum South Gold Project, setting a clear path to commence mining by Q1 2026 amid strong gold prices.

DeSoto Resources has initiated diamond drilling at its 100%-owned Fenton South Au-Cu Project in the Northern Territory, targeting a large, untested geophysical anomaly. The company also prepares to begin drilling at its fully permitted Spectrum Project, aiming to unlock multiple high-priority mineralisation targets.

Macquarie Group Limited has announced an ordinary dividend of AUD 1.4663 per security for its perpetual capital notes, payable in June 2025 with partial franking.

Macquarie Bank Limited reported an 18% rise in net profit for FY2025, driven by growth in its retail banking segment despite margin pressures, while its commodities business faced subdued markets. The bank maintained strong capital ratios and advanced its risk and technology frameworks amid regulatory scrutiny.

SciDev Limited reported a robust Q3 FY25 with revenue rising 10% and EBITDA tripling, driven by strategic US market expansion and a landmark PFAS remediation contract despite ongoing market challenges.

Astral Resources has restated its Spargoville Gold Project resource following its Maximus takeover, consolidating its group gold mineral resource to 1.76 million ounces. The update aligns Spargoville’s estimate with Mandilla’s economic assumptions, setting the stage for upcoming development.

Ampol Limited has unveiled its 2025 strategic roadmap focusing on refinery upgrades, retail expansion, and energy transition initiatives, aiming to boost margins and operational efficiency.

Sigma Healthcare’s recent merger with Chemist Warehouse Group is delivering strong earnings growth, with Normalised EBIT rising 36% in the first half of FY25. Transaction costs remain significant but the combined group’s outlook appears robust.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.